Glenmark Pharmaceuticals shares gained 2 per cent update for 30 June 2015

Glenmark Pharmaceuticals shares gained 2 per cent in afternoon trade on Tuesday after the company received a surprise approval from US FDA for Ezetimibe, the generic version of Merck-Schering Plough's cholesterol lowering drug 'Zetia'.According to market analysts, the drug has US sales of $1.8 billion. Ezetimibe may generate $250 million in cash flows for Glenmark during the exclusivity period.At 2.35 pm, shares of the drug maker were trading at Rs 991.60, up 1.93 per cent against their previous close.CLSA has set a target price of Rs 1,060 for the scrip. According to the investment firm, the pharma major is at the cusp of a revival with pick-up in US approvals.For the year ended March 2015, Glenmark Pharmaceuticals registered consolidated net profit of Rs 475.31 crore, down 12.35 per cent against Rs 542.28 crore last year.
Glenmark Pharmaceuticals shares gained 2 per cent update for 30 June 2015 Glenmark Pharmaceuticals shares gained 2 per cent update for 30 June 2015 Reviewed by Money99 on 16:08:00 Rating: 5

No comments:

Powered by Blogger.